Cellular uptake of quercetin and luteolin and their effects on monoamine oxidase-A in human neuroblastoma SH-SY5Y cells

Toxicology Reports

Volumn 1, Issue , 2014, Pages 639-649

  Bandaruk, Yauhen ^a   Mukai, Rie ^a   Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Luteolin; Monoamine oxidase A; Quercetin; Serotonin metabolism; SH SY5Y cells

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ASCORBIC ACID; DIOSMETIN; ISORHAMNETIN; LUTEOLIN; QUERCETIN;

ARTICLE; AUTOOXIDATION; CELL METABOLISM; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MITOCHONDRION; PROTEIN METHYLATION; WESTERN BLOTTING;

EID: 84922922606     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2014.08.016     Document Type: Article

References (33)

1. Shih J.C., Chen K., Ridd M.J. Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci. 1999, 22:197-217.
2. Lang U.E., Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol. Biochem. 2013, 31:761-777.
3. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., Young T., Praschak-Rieder N., Wilson A.A., Houle S. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch. Gen. Psychiatry 2006, 63:1209-1216.
4. Wimbiscus M., Kostenko O., Malone D. MAO inhibitors: risks, benefits, and lore. Clevel. Clin. J. Med. 2010, 77:859-882.
5. Youdim M.B., Riederer P. Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. J. Neural Transm. Gen. Sect. 1993, 91:181-195.
6. Dixon Clarke S.E., Ramsay R.R. Dietary inhibitors of monoamine oxidase A. J. Neural. Transm. 2011, 118:1031-1041.
7. Gong J., Huang J., Ge Q., Chen F., Zhang Y. Advanced research on the antidepressant effect of flavonoids. Curr. Opin. Complement. Altern. Med. 2014, 1:1-6.
8. Butterweck V., Jürgenliemk G., Nahrstedt A., Winterhoff H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta. Med. 2000, 66:3-6.
9. Chakraborty J., Singh R., Dutta D., Naskar A., Rajamma U., Mohanakumar K.P. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in a 3-nitropropionic acid-induced rat model of Huntington's disease. CNS Neurosci. Ther. 2013, 20:10-19.
10. Sakakibara H., Yoshino S., Kawai Y., Terao J. Antidepressant-like effect of onion (Allium cepa L.) powder in a rat behavioral model of depression. Biosci. Biotechnol. Biochem. 2008, 72:94-100.
11. Chimenti F., Cottiglia F., Bonsignore L., Casu L., Casu M., Floris C., Secci D., Bolasco A., Chimenti P., Granese A., Befani O., Turini P., Alcaro S., Ortuso F., Trombetta G., Loizzo A., Guarino I. Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study. J. Nat. Prod. 2006, 69:945-949.
12. Yoshino S., Hara A., Sakakibara H., Kawabata K., Tokumura A., Ishisaka A., Kawai Y., Terao J. Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Nutrition 2011, 21:847-852.
13. Bandaruk Y., Mukai R., Kawamura T., Nemoto H., Terao J. Evaluation of the inhibitory effects of quercetin-related flavonoids and tea catechins on the monoamine oxidase-A reaction in mouse brain mitochondria. J. Agric. Food Chem. 2012, 60:10270-10277.
14. Ishisaka M., Kakefuda K., Yamauchi M., Tsuruma K., Shimazawa M., Tsuruta A., Hara H. Luteolin shows an antidepressant-like effect via suppressing endoplasmic reticulum stress. Biol. Pharm. Bull. 2011, 34:1481-1486.
15. Sasaki K., El Omri A., Kondo S., Han J., Isoda H. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav. Brain Res. 2013, 238:86-94.
16. Dajas F., Andrés A.C., Florencia A., Carolina E., Felicia R.M. Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features. Cent. Nerv. Syst. Agents Med. Chem. 2013, 13:30-35.
17. Dounce A.L., Witter R.F., Monty K.J., Pate S., Cottone M.A. A method for isolating intact mitochondria and nuclei from the same homogenate, and the influence of mitochondrial destruction on the properties of cell nuclei. J. Biophys. Biochem. Cytol. 1955, 1:139-153.
18. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol. 1965, 14:1684-1686.
19. Ishisaka A., Ichikawa S., Sakakibara H., Piskula M.K., Nakamura T., Kato Y., Ito M., Miyamoto K., Tsuji A., Kawai Y., Terao J. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic. Biol. Med. 2011, 51:1329-1336.
20. Inaba-Hasegawa K., Akao Y., Maruyama W., Naoi M. Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells. J. Neural Transm. 2013, 120:435-444.
21. Hodnick W.F., Kalyanaraman B., Pritsos C.A., Pardini R.S. The production of hydroxyl and semiquinone free radicals during the autoxidation of redox active flavonoids. Basic Life Sci. 1988, 49:149-152.
22. Chedea V.S., Choueiri L., Jisaka M., Kefalas P. o-Quinone involvement in the prooxidant tendency of a mixture of quercetin and caffeic acid. Food Chem. 2012, 135:1999-2004.
23. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaité E., Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 1999, 26:107-116.
24. Terao J., Murota K., Kawai Y. Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Funct. 2011, 2:11-17.
25. Alberts R.W., Price D.L. Basic neurochemistry. Principles of molecular, cellular and medical neurobiology 2012, Elsevier Academic Press, London. eigth ed.
26. Fiorani M., Guidarelli A., Blasa M., Azzolini C., Candiracci M., Piatti E., Cantoni O. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J. Nutr. Biochem. 2010, 21:397-404.
27. Jones Q.R., Warford J., Rupasinghe H.P., Robertson G.S. Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol. Sci. 2012, 33:602-610.
28. Bieger J., Cermak R., Blank R., de Boer V.C., Hollman P.C., Kamphues J., Wolffram S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J. Nutr. 2008, 138:1417-1420.
29. Spencer J.P. The interactions of flavonoids within neuronal signaling pathways. Genes Nutr. 2007, 2:257-273.
30. Youdim K.A., Shukitt-Hale B., Joseph J.A. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med. 2004, 37:1683-1693.
31. Faria A., Meireles M., Fernandes I., Santos-Buelga C., Gonzalez-Manzano S., Dueñas M., de Freitas V., Mateus N., Calhau C. Flavonoid metabolites transport across a human BBB model. Food Chem. 2014, 149:190-196.
32. Spencer J.P.E., Crozier A. Flavonoids and related compounds: bioavailability and function (oxidative stress and disease) 2012, CRC Press, London.
33. Mukai R., Kawabata K., Otsuka S., Ishisaka A., Kawai Y., Ji Z.S., Tsuboi H., Terao J. Effect of quercetin and its glucuronide metabolite upon 6-hydroxydopamine-induced oxidative damage in Neuro-2a cells. Free Radic. Res. 2012, 46:1019-1028.